Eli Lilly Shares Sink, Qualcomm's Tepid Forecast, Carrier Global Rises
On this episode of Stock Movers:- Eli Lilly (LLY) shares fell the most intraday since October after CVS Health announced a plan to drop its blockbuster weight-loss drug Zepbound from its preferred list, making rival Wegovy more widely available. While the company maintained its sales guidance between $58 billion and $61 billion for the year, and Zepbound performed in line with Wall Street’s expectations, investors who had been hoping for more explosive growth were underwhelmed.- Qualcomm (QCOM) shares fell after the company gave a tepid revenue forecast, underscoring concerns that…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.